Zai Lab Limited (ZLAB)
Zai Lab Statistics
Share Statistics
Zai Lab has 10.83M shares outstanding. The number of shares has increased by 9.24% in one year.
| Shares Outstanding | 10.83M |
| Shares Change (YoY) | 9.24% |
| Shares Change (QoQ) | -0.61% |
| Owned by Institutions (%) | 5.74% |
| Shares Floating | 10.73M |
| Failed to Deliver (FTD) Shares | 8 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 6.05M, so 5.55% of the outstanding shares have been sold short.
| Short Interest | 6.05M |
| Short % of Shares Out | 5.55% |
| Short % of Float | 5.57% |
| Short Ratio (days to cover) | 12.22 |
Valuation Ratios
The PE ratio is -1.01 and the forward PE ratio is -15.21. Zai Lab's PEG ratio is 0.04.
| PE Ratio | -1.01 |
| Forward PE | -15.21 |
| PS Ratio | 0.65 |
| Forward PS | 0.2 |
| PB Ratio | 0.31 |
| P/FCF Ratio | -0.94 |
| PEG Ratio | 0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Zai Lab.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.51 |
| Quick Ratio | 3.38 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | -0.63 |
| Debt / FCF | -0.56 |
| Interest Coverage | -125.16 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $213.48K |
| Profits Per Employee | $-137.56K |
| Employee Count | 1,869 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 3.71 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 129.06% in the last 52 weeks. The beta is 1.07, so Zai Lab's price volatility has been higher than the market average.
| Beta | 1.07 |
| 52-Week Price Change | 129.06% |
| 50-Day Moving Average | 32.34 |
| 200-Day Moving Average | 25.44 |
| Relative Strength Index (RSI) | 54.88 |
| Average Volume (20 Days) | 924.95K |
Income Statement
In the last 12 months, Zai Lab had revenue of 398.99M and earned -257.1M in profits. Earnings per share was -2.6.
| Revenue | 398.99M |
| Gross Profit | 251.13M |
| Operating Income | -282.12M |
| Net Income | -257.1M |
| EBITDA | -242.99M |
| EBIT | -254.85M |
| Earnings Per Share (EPS) | -2.6 |
Balance Sheet
The company has 449.67M in cash and 153.47M in debt, giving a net cash position of 296.2M.
| Cash & Cash Equivalents | 449.67M |
| Total Debt | 153.47M |
| Net Cash | 296.2M |
| Retained Earnings | -2.45B |
| Total Assets | 1.19B |
| Working Capital | 751.1M |
Cash Flow
In the last 12 months, operating cash flow was -214.87M and capital expenditures -61.52M, giving a free cash flow of -276.39M.
| Operating Cash Flow | -214.87M |
| Capital Expenditures | -61.52M |
| Free Cash Flow | -276.39M |
| FCF Per Share | -2.79 |
Margins
Gross margin is 62.94%, with operating and profit margins of -70.71% and -64.44%.
| Gross Margin | 62.94% |
| Operating Margin | -70.71% |
| Pretax Margin | -64.44% |
| Profit Margin | -64.44% |
| EBITDA Margin | -60.9% |
| EBIT Margin | -70.71% |
| FCF Margin | -69.27% |
Dividends & Yields
ZLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ZLAB is $51, which is 40% higher than the current price. The consensus rating is "Buy".
| Price Target | $51 |
| Price Target Difference | 40% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -1.83 |
| Piotroski F-Score | 2 |